B K Kilhovd
Overview
Explore the profile of B K Kilhovd including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
220
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kilhovd B, Juutilainen A, Lehto S, Ronnemaa T, Torjesen P, Hanssen K, et al.
Diabetologia
. 2007 May;
50(7):1409-17.
PMID: 17479244
Aims/hypothesis: AGEs, modification products formed by glycation or glycoxidation of proteins and lipids, have been linked to premature atherosclerosis in patients with diabetes. We investigated whether increased serum levels of...
2.
Mentink C, Kilhovd B, Rondas-Colbers G, Torjesen P, Wolffenbuttel B
Neth J Med
. 2006 Jan;
64(1):10-6.
PMID: 16421436
Background: Several advanced glycation endproducts (AGEs) are formed in the hyperglycaemic state. Although serum AGEs correlate with average glycaemic control in patients with type 2 diabetes and predict the development...
3.
Kilhovd B, Giardino I, Torjesen P, Birkeland K, Berg T, Thornalley P, et al.
Metabolism
. 2003 Feb;
52(2):163-7.
PMID: 12601626
A time-delayed fluorescence immunoassay was developed for the determination of serum levels of methylglyoxal (MG)-derived hydroimidazolone using a monoclonal antiserum raised against Nalpha-acetyl-Ndelta-(5-hydro-5-methyl)-4-imidazolone, Europium-labeled anti-mouse IgG antiserum as indicator, and...
4.
Kilhovd B, Berg T, Birkeland K, Thorsby P, Hanssen K
Diabetes Care
. 1999 Sep;
22(9):1543-8.
PMID: 10480523
Objective: To investigate whether serum levels of advanced glycation end products (AGEs) and the glycoxidation product Nepsilon-(carboxymethyl)lysine (CML) are increased in patients with type 2 diabetes compared with nondiabetic control...